PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT)

CUSIP: 74638P208

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Ordinary Shares, no par value per share
Shares outstanding
1,806,796,154
Total 13F shares
132,491
Share change
+70,523
Total reported value
$75,781
Price per share
$0.57
Number of holders
11
Value change
+$9,482
Number of buys
5
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 74638P208?
CUSIP 74638P208 identifies PPBT - PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PPBT - PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
10%
200,453,695
$113,957,926 +$34,576,864 30 Sep 2025
Lincoln Alternative Strategies LLC
13D/G
9.9%
605,000
$1,288,650 $0 04 Sep 2025
Orca Capital AG
13D/G
4.9%
306,394
$652,619 $0 04 Sep 2025
UBS Group AG
13F
Company
0%
23,144
$54,272 30 Jun 2025
13F
KINGSWOOD WEALTH ADVISORS, LLC
13F
Company
0%
16,797
$39,389 30 Jun 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
6,275
$14,715 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0%
4,566
$10,707 30 Jun 2025
13F
GAMMA Investing LLC
13F
Company
0%
4,430
$10,388 30 Jun 2025
13F
RHUMBLINE ADVISERS
13F
Company
0%
1,080
$2,548 30 Jun 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0%
555
$1,301 30 Jun 2025
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0%
85
$199 30 Jun 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
20
$47 30 Jun 2025
13F
EverSource Wealth Advisors, LLC
13F
Company
class O/S missing
16
$38 30 Jun 2025
13F
Global Retirement Partners, LLC
13F
Company
0%
16
$38 30 Jun 2025
13F
North Star Investment Management Corp.
13F
Company
class O/S missing
15
$35 30 Jun 2025
13F

Institutional Holders of PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT) as of Q3 2025

As of 30 Sep 2025, PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 132,491 shares. The largest 10 holders included Virtu Financial LLC, CITADEL ADVISORS LLC, GAMMA Investing LLC, BNP PARIBAS FINANCIAL MARKETS, MORGAN STANLEY, UBS Group AG, RHUMBLINE ADVISERS, Tradewinds Capital Management, LLC, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, and SBI Securities Co., Ltd.. This page lists 11 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
10
Q3 2025 holders
11
Holder diff
1
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .